Lower cost sleep apnoea diagnosis feasible:
This article was originally published in Clinica
Simple nocturnal oximetry measurements are effective for diagnosing sleep apnoea hypopnea syndrome (SAHS) and can avoid the need for expensive and time-consuming polysomnographs, according to Spanish researchers. Reporting in the November edition of Thorax, a team from Hospital Universitario San Juan de Alicante assessed 275 patients with suspected SAHS and diagnosed the condition in 216 cases. The positive predictive value of oximetry was between 97% and 99%, depending on what cut-off points of oxygen desaturation were used. Sensitivity was 63% to 80%, specificity was 89% to 96% and negative predictive value was 38% to 48%.
You may also be interested in...
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.